help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katahira, M.
Right arrow Articles by Saito, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katahira, M.
Right arrow Articles by Saito, H.
Endocrinology Vol. 139, No. 5 2414-2422
Copyright © 1998 by The Endocrine Society


ARTICLES

Cytokine Regulation of the Rat Proopiomelanocortin Gene Expression in AtT-20 Cells

Masahito Katahira, Yasumasa Iwasaki, Yoshiaki Aoki, Yutaka Oiso and Hidehiko Saito

First Department of Internal Medicine, Nagoya University School of Medicine, Nagoya 466, Japan

Although cytokines are known to be involved in the regulation of ACTH secretion, their effects, along with the molecular mechanisms, on POMC gene expression are not thoroughly characterized. In this study we examined the effects of representative cytokines on transcription of the POMC gene in corticotrophs in vitro using AtT20PL, a clone of the AtT20 cell line stably transfected with approximately 0.7 kilobase of the rat POMC 5'-promoter-luciferase fusion gene. In each experiment, cells were incubated with the cytokine tested, and the changes in POMC 5'-promoter activity were determined by a luciferase assay. The results showed that interleukin-1ß (IL-1ß) stimulated promoter activity in a biphasic manner [weak short term effects (2–3 h) followed by potent long term effects (>12–16 h)]. Tumor necrosis factor-{alpha} had similar effects, but much less potency. IL-6 showed a profound stimulatory, but only a long term (>20 h), effect. IL-2 did not influence POMC expression. In contrast, interferon-{alpha} (IFN{alpha}) and IFN-{gamma} showed acute stimulatory effects (~4 h) followed by marked inhibitory effects (>8 h). Although the acute effects of IL-1ß, IL-6, and tumor necrosis factor-{alpha} alone were minimal, they significantly potentiated the stimulatory effect of CRH on POMC expression. Finally, pretreatment of the cells with a broad spectrum tyrosine kinase inhibitor, genistein, abolished or significantly diminished the effects of all cytokines except IFNs. Our results suggest that 1) each cytokine tested has a distinct effect on POMC gene expression; 2) there are positive cross-talk effects between CRH and cytokines at the corticotroph level; and 3) tyrosine phosphorylation cascades are involved in the intracellular signaling mechanisms of some cytokines.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
V. Ajdzanovic, B. Sosic-Jurjevic, B. Filipovic, S. Trifunovic, M. Manojlovic-Stojanoski, M. Sekulic, and V. Milosevic
Genistein-Induced Histomorphometric and Hormone Secreting Changes in the Adrenal Cortex in Middle-Aged Rats
Experimental Biology and Medicine, February 1, 2009; 234(2): 148 - 156.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. Labeur, D. Refojo, B. Wolfel, J. Stalla, V. Vargas, M. Theodoropoulou, M. Buchfelder, M. Paez-Pereda, E. Arzt, and G. K Stalla
Interferon-{gamma} inhibits cellular proliferation and ACTH production in corticotroph tumor cells through a novel janus kinases-signal transducer and activator of transcription 1/nuclear factor-kappa B inhibitory signaling pathway
J. Endocrinol., November 1, 2008; 199(2): 177 - 189.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Kageyama, K. Hanada, T. Nigawara, T. Moriyama, K. Terui, S. Sakihara, and T. Suda
Urocortin Induces Interleukin-6 Gene Expression via Cyclooxygenase-2 Activity in Aortic Smooth Muscle Cells
Endocrinology, September 1, 2006; 147(9): 4454 - 4462.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
F.-y. Gong, Y.-f. Shi, and J.-y. Deng
The regulatory mechanism by which interleukin-6 stimulates GH-gene expression in rat GH3 cells.
J. Endocrinol., August 1, 2006; 190(2): 397 - 406.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. N. Silverman, A. H. Miller, C. A. Biron, and B. D. Pearce
Characterization of an Interleukin-6- and Adrenocorticotropin-Dependent, Immune-to-Adrenal Pathway during Viral Infection
Endocrinology, August 1, 2004; 145(8): 3580 - 3589.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Asaba, Y. Iwasaki, M. Yoshida, M. Asai, Y. Oiso, T. Murohara, and K. Hashimoto
Attenuation by Reactive Oxygen Species of Glucocorticoid Suppression on Proopiomelanocortin Gene Expression in Pituitary Corticotroph Cells
Endocrinology, January 1, 2004; 145(1): 39 - 42.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Kariagina, D. Romanenko, S.-G. Ren, and V. Chesnokova
Hypothalamic-Pituitary Cytokine Network
Endocrinology, January 1, 2004; 145(1): 104 - 112.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. Mynard, L. Guignat, J. Devin-Leclerc, X. Bertagna, and M. G. Catelli
Different Mechanisms for Leukemia Inhibitory Factor-Dependent Activation of Two Proopiomelanocortin Promoter Regions
Endocrinology, October 1, 2002; 143(10): 3916 - 3924.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Johansson, K. Carlström, B. Ahrén, K. Cederquist, E. Krylborg, H. Forsberg, and T. Olsson
Abnormal Cytokine and Adrenocortical Hormone Regulation in Myotonic Dystrophy
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3169 - 3176.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
A. Slominski, J. Wortsman, T. Luger, R. Paus, and S. Solomon
Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress
Physiol Rev, July 1, 2000; 80(3): 979 - 1020.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. J. Hofland, W. W. de Herder, M. Waaijers, J. Zuijderwijk, P. Uitterlinden, P. M. van Koetsveld, and S. W. J. Lamberts
Interferon-{alpha}-2a Is a Potent Inhibitor of Hormone Secretion by Cultured Human Pituitary Adenomas
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3336 - 3343.
[Abstract] [Full Text]


Home page
Am. J. Clin. Nutr.Home page
S.-S. Yeh and M. W Schuster
Geriatric cachexia: the role of cytokines
Am. J. Clinical Nutrition, August 1, 1999; 70(2): 183 - 197.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Tajima, X.-M. Ma, S. R. Bornstein, and G. Aguilera
Prenatal Dexamethasone Treatment Does Not Prevent Alterations of the Hypothalamic Pituitary Adrenal Axis in Steroid 21-Hydroxylase Deficient Mice
Endocrinology, July 1, 1999; 140(7): 3354 - 3362.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
E. A. Ratovitski, M. R. Alam, R. A. Quick, A. McMillan, C. Bao, C. Kozlovsky, T. A. Hand, R. C. Johnson, R. E. Mains, B. A. Eipper, et al.
Kalirin Inhibition of Inducible Nitric-oxide Synthase
J. Biol. Chem., January 8, 1999; 274(2): 993 - 999.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Chesnokova, A. Kariagina, and S. Melmed
Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation
Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1110 - E1118.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society